Results 321 to 330 of about 823,716 (355)

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

Lancet, The, 2017
Joseph J Eron, Daniel Podzamczer, Jonathan B Angel   +2 more
exaly  

Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients

Lancet, The, 1997
Hillel W Cohen
exaly  

Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

Lancet, The, 2016
Sally E Wenzel, Mario Castro, Jonathan Corren   +2 more
exaly  

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

Lancet, The, 2016
Dave Singh, Alberto A Papi, Massimo Corradi   +2 more
exaly  

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

New England Journal of Medicine, 2020
Chloe Orkin, Edgar T Overton, Christopher Bettacchi   +2 more
exaly  

A Long-Acting Sulfonamide

Military Medicine, 1961
openaire   +2 more sources

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

Lancet, The, 2011
Marc Peeters
exaly  

The oncologic burden of hepatitis C virus infection: A clinical perspective

Ca-A Cancer Journal for Clinicians, 2017
Harrys A Torres, Nassim Hammoudi, V Olivier Mallet   +2 more
exaly  

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial

Lancet, The, 2017
Jørgen Vestbo, Alberto A Papi, Massimo Corradi   +2 more
exaly  

Reductions in pregnancy rates in the USA with long-acting reversible contraception: a cluster randomised trial

Lancet, The, 2015
Corinne H Rocca, Suzan Goodman, Cynthia Harper   +2 more
exaly